Long-Term Supply & Consistent Quality for Your Commercial Success

PARI provides comprehensive analytical services for product development in combination with nebuliser customisation from early phase to submission and commercialisation.

Establishing your breakthrough therapy needs an efficient, high-quality nebulizer. With two production facilities in Germany, we guarantee scalable manufacturing, timely delivery and longterm availability – from clinical trial devices to full-scale commercial supply.
 

Expert Interview: Commercialization stage

Matthias Brosig, Director eFlow Alliance Operations, shares insights how we transmit drug-nebulizer combination products efficiently from development to commercial stage while supporting your market access activities.

How You Benefit from Partnering with Us

  • 20+ years of expertise in mesh nebulizer development and sustainable partnerships for your success
  • German engineering and rigorous quality control, backed by ISO 13485 certification and regular audits
  • Consistent high quality with automated manufacturing and in-process control for every component and device
  • Seamless transition from small-batch production to global commercialization
  • Secure supply chain with efficient management for reliable, on-time delivery
Highly automated mesh manufacturing capabilities
Highly automated mesh manufacturing capabilities.


Secure a reliable device supply for your breakthrough therapy!

eFlow-partneringpari.com

Two smiling men in a blue circle. The central man wears glasses and a light blue shirt. The man on the left has a beard and a blue patterned shirt.

PARI Business Development Team